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Abstract
Background: The interleukin (IL) 4/IL13 pathway is in-
volved in the regulation of IgE production associated
with atopic diseases. Numerous polymorphisms have
been identified in the coding region of the IL4 receptor ·
chain (IL4Ra) and previous association studies have
shown conflicting results. Based on their putative func-
tional role, polymorphisms A148G, T1432C and A1652G,
located in the coding region of IL4Ra, were selected for
association and haplotype studies in a large German
population sample (n = 1,120). Methods: Genotyping
was performed using allele-specific PCR and restriction-
enzyme-based assays. Haplotypes were estimated, and
population-derived IgE percentiles (50% IgE 160 IU/ml,
66% IgE 1115 IU/ml and 90% IgE 1457 IU/ml) were calcu-
lated as outcome variables in a haplotype trend regres-
sion analysis. Results: In our population, only polymor-
phism T1432C showed a trend for a protective effect
against atopic rhinitis (odds ratio, OR: 0.52, 95% confi-
dence interval, CI: 0.26–1.02, p = 0.05). When haplotypes
were calculated, one haplotype was significantly associ-
ated with elevated serum IgE levels at the 50th percentile
(OR 1.60, 95% CI 1.08–2.37, p = 0.02). Conclusions: These
data indicate that IL4Ra polymorphisms, although sug-
gested to be functionally relevant by in vitro studies,
have only a minor influence on IgE regulation in our
large population sample.
Copyright © 2004 S. Karger AG, Basel
Introduction
The switching of immunoglobulin production from
IgM to IgE in activated B lymphocytes is common to all
atopic diseases. Two of the most important cytokines
involved in IgE switching and the persistence of the aller-
gic reaction are the pro-inflammatory molecules interleu-
kin (IL) 4 and IL13. Both IL4 and IL13 affect the expres-
sion of IgE by signaling through a common pathway.
Binding of IL4 and IL13 is facilitated through a hetero-
dimeric surface receptor consisting of the IL4 receptor ·
chain (IL4Ra) and either the common Á chain (for IL4
and IL13) or the · chain of the IL13 receptor (for IL13
only) [1–3]. On interaction with the receptor, intracellular
signaling is initiated through the phosphorylation of sig-
nal transducer and activator of transcription 6 (STAT6)
molecules which in turn penetrate the nucleus activating
the transcription of target genes [4]. Located on chromo-
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some 16q12, ILRa has been associated initially with the
hyper-IgE syndrome [5, 6], IgE regulation and the devel-
opment of atopic diseases [7]. At least 14 polymorphisms
have been described in the coding region of the gene, 10 of
which lead to changes in the putative amino acid se-
quence [8]. However, association studies on the effect of
single IL4Ra polymorphisms on IgE regulation and the
development of atopic diseases have lead to conflicting
results [9–13].
Thus, we genotyped a large German population sample
(n = 1,120) for three common single nucleotide polymor-
phisms (SNPs) located in the extracellular domain and
two in the intracellular domain of the ·-chain of the recep-
tor, spanning the whole IL4Ra gene. Haplotype analysis
was performed to investigate interactions between poly-
morphisms within the IL4Ra gene.
Methods
The population used in this study has been described in detail
previously [14–16]. Therefore, only methods pertaining to this anal-
ysis are given below. Informed written consent was obtained from
all parents, and all study methods were approved by the ethics com-
mittees of the Bavarian Medical Council and the University of
Leipzig.
Subjects
In this study, only children of German origin, 9–11 years of age,
from Munich (southern Germany) and Leipzig (eastern Germany)
who had both DNA and IgE data available were included in the anal-
ysis (n = 1,120, Munich n = 528, Leipzig n = 592). No significant
differences between the study populations from both cities were
found with respect to population characteristics [15]. The schools
sent parental self-completion questionnaires on to the families. Chil-
dren underwent skin prick testing, blood was collected for serum IgE
measurements, and DNA extraction was performed from leukocytes.
No selection bias was detected between those included and those who
were not included in the study (data not shown).
Questionnaire
Children whose parents reported a doctor’s diagnosis of either
asthma, recurrent spastic or recurrent asthmatic bronchitis were clas-
sified as having asthma. Children were classified as having allergic
rhinitis or atopic dermatitis when parents reported a doctor’s diagno-
sis of hay fever or atopic eczema, respectively.
Skin Prick Test
In Munich and Leipzig, the sensitivity to six common aeroaller-
gens (Dermatophagoides pteronyssinus, Dermatophagoides farinae,
Alternaria tenuis, cat dander and mixed grass and tree pollens) was
assessed using highly standardized extracts and lancets (ALK, Hors-
holm, Denmark). A child was considered atopic if a wheal reaction of
more than 3 mm occurred to at least one specific allergen after sub-
traction of the negative control.
Total Serum IgE Measurements
Total serum IgE levels were measured using the Insulite system
(DPC Biermann, Bad Nauheim, Germany). Based on the cross-sec-
tional survey of children aged 9–11 years (International Study of
Childhood Asthma and Allergy; n = 3,063), IgE percentiles were cal-
culated. For haplotype analysis, the 50th (60.4 U/ml), 66th (115 U/
ml) and 90th percentiles (457 U/ml) for total serum IgE were used as
outcome variables. Percentiles were chosen for our haplotype analy-
sis as they may better reflect the distribution of IgE levels in the pop-
ulation. As no differences in IgE levels were observed between sub-
jects included/not included in the study or between populations from
Leipzig and Munich (data not shown), percentiles may be assumed to
be representative for a general German population aged 9–11 years
where 50th, 66th and 90th percentiles correlate with modestly, mod-
erately and highly elevated serum IgE levels.
Molecular Genetic Methods
Genomic DNA was extracted from whole blood by a standard
salting out method [17]. All PCR reactions were carried out in a vol-
ume of 15 Ìl containing 24 ng of genomic DNA using standard ther-
mocyclers (Eppendorf, Cologne, Germany). For initial genotyping,
allele-specific PCR and standard sequencing were used to genotype
the study population for three specific polymorphisms in the IL4
receptor gene. Specific primer and assay conditions used for genotyp-
ing are given in table 1. The reproducibility of genotyping results was
tested by restriction-endonuclease-based assays in at least 10% of
random repeats. Hardy-Weinberg equations were calculated for all
genotypes.
Statistical Analysis
Standard analysis of variance (ANOVA) for quantitative traits
and ¯2 tests for qualitative traits were used to compare means and
proportions between groups. Total serum IgE levels were summa-
rized descriptively with geometric means, and linear trends were
tested in ANOVA models of log-transformed values. The haplotype
trend regression model, where the estimated probabilities are mod-
eled in a logistic regression for their association with a specific trait
[18, 19], was used to calculate haplotype frequencies not directly
observable in unrelated individuals. Two additional haplotyping
methods were applied to confirm results, where the probabilities of
each haplotype were dichotomized into binary variables using two
predefined thresholds (Pr 10.80 and 10.0), followed by a ¯2 test for
association [20]. Only results consistent over all three haplotyping
methods were reported. All haplotype analyses were carried out using
SAS/Genetics, version 8.2 [19].
Results
The study population (n = 1,120) was genotyped for
the three putatively functional polymorphisms A148G,
T1432C and A1652G in the IL4Ra gene. No selection
bias was detected between those included and not in-
cluded in the study (data not shown). Genotyping was suc-
cessful in at least 95% of all samples: 1,092 samples for
A148G, 1,074 for T1432C and 1,081 for A1652G. Allele
frequencies were 0.57 for A at position 148, 0.87 for T at
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Table 1. Primers and assay conditions
SNP Forward (5)) primer
Reverse (3)) primer
Product
bp
Genotyping
assay
IL4Ra A148G ACTCCGCCCTGCTCACC
TAGGCAGGTGTGAGGAGTATC
409 BciIV 
IL4Ra A148G GCC TCC GTT GTT CTC AGG TA
TGT GAG GAG CAT CCT TGG TAC
267 RsaI 
IL4Ra A148G GCC TCC GTT GTT CTC AGG TAT
GCC TCC GTT GTT CTC AGG TAC
ATC CTT GGT GCA TGT GGT AAG
GCT TAT ACC CCT CTT CCC CAC
ACG CCC CTC GTC ATC GCA G
257
439 
asPCR
IL4Ra T1432C GAC ACG GTG ACT GGC TCG AGG
GCA TCG CCT GAG AGC AGC AG
373 BseRI 
IL4Ra T1432C GCT CTC TGG GAC ACG GTG ACT GGC TCT CGG
ATG GGG GAG TCA TGC CTT CTT CCA CCC TCG G
259 AvaI 
IL4Ra A1652G GCT TAT ACC CCT CTT CCC CAC
ACG CCC CTC GTC ATC GCA G
CAC CGC ATG TAC AAA CTC CC
CCC CCA CCA GTG GCT ATC A
439
288
189 
asPCR
asPCR
asPCR
asPCR
IL4Ra A1652G CAA AGG TGA ACA AGG GGA CAG GGA CTC G
GTC TCG GCC CCC ACC AGT GGC TCT C
265 AvaI 
asPCR = Allele-specific PCR. Underlined bases represent mismatches introduced for restriction-enzyme-based
digestions.
Table 2. IL4Ra haplotypes based on the
polymorphisms A148G, A1652G and
T1432C and haplotype frequencies (haplo-
types with frequencies !3% were not consid-
ered)
No. Haplotypes Frequencies
1 A-A-T 0.47
2 A-G-C 0.05
3 A-G-T 0.05
4 G-A-T 0.31
5 G-G-C 0.07
6 G-G-T 0.04
position 1432 and 0.80 for A at position 1652, respective-
ly. No significant deviation from the Hardy-Weinberg
equilibrium was observed with any polymorphism. Using
a correlation coefficient (¢), the linkage disequilibrium
between the three SNPs was assessed to be low to moder-
ate between all three SNPs (¢ = 0.11 for A148G and both
other polymorphisms and ¢ = 0.66 for T1432C vs.
A1652G. Allele frequencies for the genotyped IL4Ra
polymorphisms were similar to previously reported fre-
quencies in Europeans, but differed from those reported
in non-Caucasian populations [8, 20–23].
To assess the role of IL4 receptor polymorphisms in
the development of asthma and atopy, association studies
were performed, and the main atopic phenotypes of asth-
ma, atopic rhinitis, atopic dermatitis, atopy by skin prick
test and serum IgE were assessed. Only polymorphism
T1432C showed a trend for a protective effect against the
development of atopic rhinitis (T1432C: 0.52, 95% confi-
dence interval, CI: 0.26–1.02, p = 0.05). Furthermore, for
A148G a borderline significant trend towards elevated
serum IgE levels was observed: geometric means for
serum IgE (IU/ml) were 47.1 in individuals with the wild-
type allele versus 55.5 in carriers of the G allele (p = 0.08),
respectively.
Next we performed a haplotype analysis comprising
the three polymorphisms A148G, A1652G and T1432C.
When haplotypes were estimated using the ER method in
the 1,043 samples for which complete genotyping infor-
mation was available, only six of eight possible haplotypes
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Fig. 1. ORs and 95% CIs for IgE percentiles
(50th, 66th and 90th percentiles) by IL4Ra
haplotypes GAT and AAT(calculated using
the haplotype trend regression model).
exceeded a frequency of 3% (table 2). For the haplotype
analysis, percentiles for serum IgE levels based on our
cross-sectional study in a German population were calcu-
lated instead of the widely used arbitrary cutoff point for
elevated serum IgE levels of 100 IU/ml. As shown in fig-
ure 1, we observed a risk haplotype G-A-T with odds
ratios of 1.60 (95% CI 1.08–2.37, p = 0.02), for serum IgE
levels above the 50th percentile, while the risk for ele-
vated IgE at the 66th and 90th percentiles was not
increased significantly. In contrast, the haplotypic combi-
nation A-A-T showed a protective effect against the devel-
opment of elevated IgE levels with odds ratios of 0.68
(95% CI 0.48–0.97, p = 0.03) for serum IgE above the
50th percentile. No associations between haplotypes and
asthma, atopic diseases or atopy were observed (data not
shown). All other haplotype combinations were too infre-
quent to perform adequate haplotype analysis (data not
shown).
Discussion
The three polymorphisms tested in our population
sample lead to putative amino acid changes. A148G leads
to an amino acid change at position 50 of the extracellular
domain of the receptor chain (Ile50Val). In vitro studies
have shown increased IL4-dependent signaling and ele-
vated IgE production in the presence of the A (Ile) allele
[24]. In our study however, these findings were not con-
firmed in our large study cohort. In contrast, carriers of
the A allele showed a trend towards lower levels of serum
IgE. Results from Japanese [24, 25] and European studies
[23] were also conflicting. In summary, these results indi-
cate that A148G may have only minor effects (if any) on
the regulation of serum IgE levels or the development of
atopic phenotypes.
Polymorphisms T1432C and A1652G lead to amino
acid changes in Ser478Pro and Gln551Arg, respectively,
in the intracellular domain of the IL4Ra chain. Thus, both
polymorphisms have been suspected to influence the
intracellular activation of the signaling cascade. As poly-
morphism A1652G is located one base pair from a
STAT6-recruiting domain in IL4Ra, a functional rele-
vance seemed possible. While Kruse et al. [1] showed an
effect of the polymorphism on phosphorylation and sig-
nalling transduction, no such effect was observed in
another functional study [26]. In association studies, con-
flicting results for both polymorphisms in different popu-
lations and ethnicities exist. While an association was ini-
tially observed in an inbred population of German ances-
tors (Hutterites) [20] and a study cohort from southern
Germany [21], no such association was observed in our
population sample or the German Multicenter Atopy
Study [23].
To assess the effects of haplotypes in our cross-section-
al study of unrelated subjects, haplotypes were estimated
according to standard methods using the expectation
maximization algorithm. Using this procedure, only weak
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Fig. 2. Comparative analysis of respective
IL4Ra polymorphism effects on asthma. Re-
spective allele frequencies were taken from
previous reports, and ORs were calculated
and evaluated graphically. Mitsuyasu et al.
[24] studied asthma in adults and children.
but significant associations between the regulation of
serum IgE levels and IL4Ra haplotypes were detected.
While the risk haplotype G-A-T conferred a risk for mod-
estly elevated serum IgE levels (at the 50th percentile), the
A-A-T haplotype was protective at the same level. As
shown in figure 1, the same trends for associations were
observed for the 66th and 90th percentiles. However, as
fewer observations contribute to these associations, the
statistical significance decreased.
Only three out of 14 known polymorphisms in the
IL4Ra-coding region were genotyped in our population
and included in the haplotype analysis. However, it has
been shown previously that other polymorphisms in the
IL4Ra gene and the IL4R promoter were either very infre-
quent or in strong linkage disequilibrium with the poly-
morphisms genotyped here [20, 22, 27]. Thus, it seems
unlikely that further, non-genotyped polymorphisms in
the IL4Ra gene may confer significant effects on IgE regu-
lation or the development of atopic diseases.
Even though a large body of literature exists on the puta-
tive effects of genetic variations in the IL4Ra gene on the
development of atopic diseases and the regulation of serum
IgE levels, it was not possible to perform a meta-analysis of
the current literature. This was due to a lack of standardiza-
tion between reports in terms of the phenotypes assessed,
statistical methods and the presentation of the results of
genotyping. In figure 2, results from association studies
accessible for a comparative analysis of the effects of poly-
morphisms A148G, T1432C and A1652G on asthma are
summarized descriptively. As shown in this comparison,
results vary greatly between different studies and popula-
tions. In our cross-sectional study, no significant associa-
tion between IL4Ra polymorphisms and asthma was ob-
served (fig. 2). However, small genetic effects requiring an
even larger study population may have been missed.
In conclusion, our data suggest that IL4Ra polymor-
phisms exert only a minor effect on the regulation of
serum IgE and do not contribute significantly to the devel-
opment of atopic diseases in our large study cohort of
German children. However, it cannot be excluded that
IL4Ra polymorphisms interact with polymorphisms in
other genes of the IL4/IL13 pathway or certain environ-
mental factors that may have modifying effects on IgE
regulation and the development of atopic diseases. While
some aspects of these possible interactions, e.g. between
IL13 and IL4Ra polymorphisms, have already been ad-
dressed [23, 28], further studies on the complete pathway
including IL4, IL13, IL4Ra and the intracellular signal
transducer STAT6 may be necessary to elucidate the com-
plex genetic regulation of serum IgE levels.
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